Eli Lilly's Alzheimer's drug donanemab can slow disease: Study
Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
Source: 13newsnow.com
Page 10 - Mark Mintun News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Mintun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Mintun Today - Breaking & Trending Today
Second Alzheimer's drug can slow disease by a few months
Another experimental Alzheimer's drug can modestly slow patients' inevitable worsening — by about four to seven months, researchers reported Monday.
Source: democratherald.com
Experimental Alzheimer's Drug Slows Thinking Declines in Late-Stage Trial
MONDAY, July 17, 2023 (HealthDay News) -- Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing
Source: kulr8.com
Experimental Alzheimer's drug donanemab may slow symptoms by a third
Another experimental drug meant to slow the damage of Alzheimer's appears poised to join a growing arsenal of new treatments for this memory-robbing disease.
Source: upi.com
Second Alzheimer's drug in the pipeline promises to slow worsening but with safety concern | Science & Tech
Patients given monthly infusions of Eli Lilly and Co.’s donanemab declined about four to seven months more slowly than those given dummy infusions in a large study
Source: elpais.com